FibroGen Inc header image

FibroGen Inc

FGEN

Equity

ISIN null / Valor 25953994

NASDAQ (2026-03-27)

USD 6.59+0.76%

FibroGen Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

FibroGen Inc is a biopharmaceutical company focused on developing innovative therapies for various medical conditions. One of their potential first-in-class products is FG-3246, an antibody-drug conjugate being developed for metastatic castration-resistant prostate cancer and other tumor types. Another promising drug in their pipeline is Pamrevlumab, a human monoclonal antibody designed to inhibit the activity of connective tissue growth factor in proliferative disorders and certain cancer cell types. Additionally, FibroGen is working on Roxadustat, an oral small molecule inhibitor for treating chemotherapy-induced anemia. These investigational drugs are at various stages of clinical development and have the potential to address significant unmet medical needs in the market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-19.6%1Y

-98.6%3Y

-99.2%5Y

Performance

74.7%1Y

156%3Y

131%5Y

Volatility

27 M

Market cap (USD)

30,993

Daily traded volume (Shares)

0.59 / 0.5133

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc Valor: 30877188

Annual Return

-50%0%+50%

Risk level

110

-2.82%USD 72.15

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

SIX

FactSet

Clearbit

Logos provided by Clearbit